Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06043063 · ClinicalTrials.gov registry record · NA
Local Anesthesia Before Bulkamid Injection
A NA study, sponsored by Medstar Health Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT06043063 is a NA study that was terminated before completion, run by Medstar Health Research Institute. The registered enrollment target is 23 participants.
The verdict
NCT06043063, a NA study, was terminated before completion, sponsored by Medstar Health Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
While recommended pre-anesthesia for polyacylamide hydrogel (PAHG, Bulkamid) injections for stress urinary incontinence and intrinsic sphincter deficiency can include intraurethral anesthetic gel with or without periurethral block, there is no existing literature to guide choice of anesthesia. This is a single-blinded randomized control trial to evaluate post-procedure pain with choice of anesthesia before PAHG injection.
Interventions
- PROCEDURE Topical lidocaine
- PROCEDURE EMLA cream
- PROCEDURE Periurethral block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2024-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06043063
The ClinicalTrials.gov registry entry for NCT06043063 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Topical lidocaine is the first listed.
NCT06043063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06043063 about?
NCT06043063 is a clinical study titled "Local Anesthesia Before Bulkamid Injection". While recommended pre-anesthesia for polyacylamide hydrogel (PAHG, Bulkamid) injections for stress urinary incontinence and intrinsic sphincter deficiency can include intraurethral anesthetic gel with or without periurethral block, there is no existing literature to guide choice of anesthesia. This ...
What is the current status of trial NCT06043063?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2023-09-01. Estimated completion is 2024-12-23.
What interventions are being tested in trial NCT06043063?
The interventions under investigation include: Topical lidocaine (PROCEDURE), EMLA cream (PROCEDURE), Periurethral block (PROCEDURE).
Who is sponsoring clinical trial NCT06043063?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.